Hiv Vaccine Current Events | Hiv Vaccine News | 6
|
| Page
6 of
63 |
1256 Results |
|
|
|
Sort By:
Page Views | Date |
Researchers seek to solve mystery of natural HIV control
An international, multi-institutional research consortium is seeking to discover how a few HIV-infected individuals are naturally able to suppress replication of the virus. view more (2006-08-17)
HIV positive and HIV negative patients have similar survival rates following liver transplant
HIV positive and HIV negative patients have comparable survival rates following liver transplant, according to new research presented today at EASL 2009, the Annual Meeting of the European Association for the Study of Liver in Copenhagen, Denmark. view more (2009-04-24)
Circumcision for prevention of HIV: new analysis demonstrates cost-effectiveness
A team of researchers who conducted a landmark trial in Orange Farm, South Africa, which concluded that male circumcision can sub stantially reduce the risk of becoming infected with HIV, have now studied the economic aspects of this approach to preventing HIV/AIDS. view more (2006-12-26)
New chemically-activated antigen could expedite development of HIV vaccine
Scientists working to develop a vaccine for the human immunodeficiency virus (HIV) report they have created the first antigen that induces protective antibodies capable of blocking infection of human cells by genetically-diverse strains of HIV. view more (2009-09-22)
Antiretroviral Therapy Effective In Reducing Mother-to-child HIV-1 Transmission When Started After Childbirth (p 1171)
Results of a study from Malawi in this week's issue of THE LANCET highlight how antiretroviral therapy targeted at babies soon after childbirth (because their mothers' HIV diagnosis was made around the time of delivery) is still effective in preventing vertical HIV-1 transmission from mothers to their children. Zidovudine and nevirapine have been... view more... (2003-10-08)
First genome-wide study of infectious disease opens new avenues for HIV treatment, vaccines
The first genome-wide association study of an infectious disease, conducted by an international group of researchers through the Center for HIV/AIDS Vaccine Immunology (CHAVI), has yielded a new understanding of why some people can suppress virus levels following HIV infection. view more (2007-07-23)
Nanoemulsion vaccines show increasing promise
A novel technique for vaccinating against a variety of infectious diseases - using an oil-based emulsion placed in the nose, rather than needles - has proved able to produce a strong immune response against smallpox and HIV in two new studies. view more (2008-02-27)
Increase in malaria linked to HIV
People in developing countries with HIV-1 infection may be twice as likely to develop malarial infection and disease compared with HIV-1-negative individuals, according to research published in this week's issue of THE LANCET. An association between HIV-1 and malaria is expected in theory, but has not been convincingly shown in practice. James... view more... (2000-09-20)
A new step towards an AIDS vaccine
Progressive disease after HIV infection is inversely correlated with the presence of plasmacytoid dendritic cells (pDCs), a subset of the dendritic cell family and the major producers of type 1 interferon in the body. view more (2005-10-14)
AIDS vaccine research offers new insights on survival
New insights into how a subpopulation of helper T-cells provides immunity and promotes survival following infection with an AIDS-like virus offer a new means of predicting an AIDS vaccine's effectiveness, a discovery that could help scientists as they test these vaccines in clinical trials. view more (2006-06-12)
A low prevalence of H pylori in HIV-positive patients
Helicobacter pylori has been extensively studied and proven to be the main cause of chronic gastritis and peptic ulcer in the HIV-negative population. view more (2007-10-17)
HIV conquers immune system faster than previously realized
New research into the earliest events occurring immediately upon infection with HIV-I shows that the virus deals a stunning blow to the immune system earlier than was previously understood. view more (2008-07-21)
Why are so few HIV/AIDS trials conducted in Africa?
People in sub-Saharan Africa carry the heaviest burden of HIV and AIDS, yet very few trials have been conducted on the African continent over the past two decades, say researchers in this week's BMJ. view more (2005-09-30)
OHSU researchers discover possible HIV therapy in an animal study
Researchers have published a new study this week suggesting an important component of the immune system damaged by AIDS can possibly be replaced. view more (2006-06-09)
New vaccine protects more effectively against tuberculosis
Globally, tuberculosis remains the number one killer in adults. Moreover, multi-drug-resistant tuberculosis strains are on the rise which cannot be treated by first-line drugs. view more (2005-08-29)
Scripps Research scientists shed new light on how antibodies fight HIV
By furthering scientists' understanding of the molecular mechanisms that separate the minority of successful HIV antibodies from the majority of ineffective antibodies, the work may have implications for future attempts to design an HIV vaccine. view more (2007-09-07)
MicroRNAs help control HIV life cycle
Scientists at Burnham Institute for Medical Research (Burnham) have discovered that specific microRNAs (non-coding RNAs that interfere with gene expression) reduce HIV replication and infectivity in human T-cells. view more (2009-06-26)
Fractional dose of scarce meningitis vaccine may be effective in outbreak control
One fifth of the standard dose of a commonly used meningitis vaccine may be as effective as using the full dose. view more (2008-12-05)
Immune exhaustion in HIV infection
As HIV disease progresses in a person infected with the HIV virus, a group of cells in the immune system, the CD8+ T lymphocytes, become "exhausted," losing many of their abilities to kill other cells infected by the virus. view more (2008-05-06)
Hopkins joins Ugandan researchers to study pediatric AIDS vaccine
Scientists at Makerere University, in Kampala, Uganda, along with scientists from Johns Hopkins and other institutions worldwide, have begun the first clinical safety trial in Africa of a vaccine to prevent mother-to-child transmission of HIV through breastfeeding. view more (2006-10-13)
|
|
| Page
6 of
63 |
1256 Results |
|
|
|
Sort By:
Page Views | Date |
|
